ArticleMedical oncology (Northwood, London, England)2022

E2F2 enhances the chemoresistance of pancreatic cancer to gemcitabine by regulating the cell cycle and upregulating the expression of RRM2.

Qianfan Liu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.